Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Michelle Noone

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2026
Trends in Long-Term Excess Mortality Risk and Survival Among Childhood and Adolescent Cancer Survivors in the United StatesYoon Duk Hong, Theresa P Devasia, Nita L Seibel, et al.
Medical Care|April 13, 2026
Response to Letter to the Editor: Compliance With Recommendations of the Surveillance, Epidemiology, and End Results (SEER) Treatment Data Use Agreement: A Review of Published StudiesYoon Duk Hong, Angela B Mariotto, Denise R Lewis, et al.
Gastrointestinal Cancer Research : GCR|September 11, 2009
Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancersJun F Sun, Rebekah R Wu, Craig Norris, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 27, 2010
Metabolism of isothiocyanates in individuals with positive and null GSTT1 and M1 genotypes after drinking watercress juiceMarcin Dyba, Antai Wang, Anne-Michelle Noone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2016
Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013Anne-Michelle Noone, Kathleen A Cronin, Sean F Altekruse, et al.
Journal of Community Health|August 2, 2011
Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant LatinosSherrie Flynt Wallington, Gheorghe Luta, Anne-Michelle Noone, et al.
Medical Care|September 22, 2025
Compliance With Recommendations of the Surveillance, Epidemiology, and End Results (SEER) Treatment Data Use Agreement: A Review of Published StudiesYoon Duk Hong, Angela B Mariotto, Denise R Lewis, et al.
Journal of the National Cancer Institute|September 24, 2024
Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 declineNadia Howlader, Huann-Sheng Chen, Anne-Michelle Noone, et al.
JCO Clinical Cancer Informatics|June 7, 2021
Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based RegistriesAnne-Michelle Noone, Clara J K Lam, Angela B Smith, et al.
Journal of the National Cancer Institute. Monographs|November 24, 2014
Cancer survival: an overview of measures, uses, and interpretationAngela B Mariotto, Anne-Michelle Noone, Nadia Howlader, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2026
Trends in Long-Term Excess Mortality Risk and Survival Among Childhood and Adolescent Cancer Survivors in the United StatesYoon Duk Hong, Theresa P Devasia, Nita L Seibel, et al.
Medical Care|April 13, 2026
Response to Letter to the Editor: Compliance With Recommendations of the Surveillance, Epidemiology, and End Results (SEER) Treatment Data Use Agreement: A Review of Published StudiesYoon Duk Hong, Angela B Mariotto, Denise R Lewis, et al.
Gastrointestinal Cancer Research : GCR|September 11, 2009
Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancersJun F Sun, Rebekah R Wu, Craig Norris, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 27, 2010
Metabolism of isothiocyanates in individuals with positive and null GSTT1 and M1 genotypes after drinking watercress juiceMarcin Dyba, Antai Wang, Anne-Michelle Noone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2016
Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013Anne-Michelle Noone, Kathleen A Cronin, Sean F Altekruse, et al.
Journal of Community Health|August 2, 2011
Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant LatinosSherrie Flynt Wallington, Gheorghe Luta, Anne-Michelle Noone, et al.
Medical Care|September 22, 2025
Compliance With Recommendations of the Surveillance, Epidemiology, and End Results (SEER) Treatment Data Use Agreement: A Review of Published StudiesYoon Duk Hong, Angela B Mariotto, Denise R Lewis, et al.
Journal of the National Cancer Institute|September 24, 2024
Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 declineNadia Howlader, Huann-Sheng Chen, Anne-Michelle Noone, et al.
JCO Clinical Cancer Informatics|June 7, 2021
Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based RegistriesAnne-Michelle Noone, Clara J K Lam, Angela B Smith, et al.
Journal of the National Cancer Institute. Monographs|November 24, 2014
Cancer survival: an overview of measures, uses, and interpretationAngela B Mariotto, Anne-Michelle Noone, Nadia Howlader, et al.
Pageof 7